Related Experiment Video
Updated: Dec 26, 2025

Estrogen-Like Effect of Bazi Bushen Capsule in Ovariectomized Rats
Published on: April 7, 2023
Oestrogen-activated autophagy has a negative effect on the anti-osteoclastogenic function of oestrogen
Liang Cheng1, Yunrong Zhu2, Dianshan Ke1
1Guangdong Provincial Key Laboratory of Bone and Joint Degeneration Diseases, The Third Affiliated Hospital of Southern Medical University, Guangzhou, China.
Objectives:
Oestrogen is known to inhibit osteoclastogenesis, and numerous studies have identified it as an autophagic activator. To date, the role of oestrogen in the autophagy of osteoclast precursors (OCPs) during osteoclastogenesis remains unclear. This study aimed to determine the effect of autophagy regulated by the biologically active form of oestrogen (17β-estradiol) on osteoclastogenesis.
Materials And Methods:
After treatment with 17β-estradiol in OCPs (from bone marrow-derived macrophages, BMMs) and ovariectomy (OVX) mice, we measured the effect of 17β-estradiol on the autophagy of OCPs in vitro and in vivo. In addition, we studied the role of autophagy in the OCP proliferation, osteoclast differentiation and bone loss regulated by 17β-estradiol using autophagic inhibitor or knock-down of autophagic genes.
Results:
The results showed that direct administration of 17β-estradiol enhanced the autophagic response of OCPs. Interestingly, 17β-estradiol inhibited the stimulatory effect of receptor activator of nuclear factor-κB ligand (RANKL) on the autophagy and osteoclastogenesis of OCPs. Moreover, 17β-estradiol inhibited the downstream signalling of RANKL. Autophagic suppression by pharmacological inhibitors or gene silencing enhanced the inhibitory effect of 17β-estradiol on osteoclastogenesis. In vivo assays showed that the autophagic inhibitor 3-MA not only inhibited the autophagic activity of the OCPs in the trabecular bone of OVX mice but also enhanced the ability of 17β-estradiol to ameliorate bone loss.
Conclusions:
In conclusion, our study showed that oestrogen directly enhanced the autophagy of OCPs, which inhibited its anti-osteoclastogenic effect. Drugs based on autophagic inhibition may enhance the efficacy of oestrogen on osteoporosis.
Insights
Oestrogen enhances osteoclast precursor autophagy, which paradoxically inhibits its bone-protective effects. Autophagy inhibition may boost oestrogen therapy for osteoporosis.
Area of Science:
- Endocrinology
- Cell Biology
- Bone Biology
Background:
- Oestrogen is known to inhibit osteoclastogenesis and activate autophagy.
- The specific role of oestrogen-regulated autophagy in osteoclast precursors (OCPs) during osteoclastogenesis is not fully understood.
Purpose of the Study:
- To investigate the effect of 17β-estradiol, the active form of oestrogen, on OCP autophagy and its subsequent impact on osteoclastogenesis.
- To elucidate the mechanism by which oestrogen influences OCPs and bone metabolism.
Main Methods:
- OCPs derived from bone marrow-derived macrophages (BMMs) were treated with 17β-estradiol in vitro.
- Ovariectomy (OVX) mouse models were used for in vivo studies.
- Autophagic inhibitors and gene silencing were employed to study the role of autophagy in OCP proliferation, differentiation, and bone loss.
Main Results:
- 17β-estradiol treatment directly enhanced autophagy in OCPs.
- This enhanced autophagy counteracted the inhibitory effect of 17β-estradiol on RANKL-induced osteoclastogenesis and downstream signaling.
- Pharmacological or genetic suppression of autophagy amplified the anti-osteoclastogenic and bone-protective effects of 17β-estradiol in OVX mice.
Conclusions:
- Oestrogen directly promotes OCP autophagy, which appears to inhibit its own anti-osteoclastogenic activity.
- Targeting autophagy inhibition could potentially enhance the therapeutic efficacy of oestrogen for treating osteoporosis.
Related Concept Videos
Osteoclasts in Bone Remodeling
Bone Remodeling
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Delivery Pathways to the Lysosome
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...

